Dietz S, Lemm H, Bushnaq H, Hobbach H-P, Werdan K, Buerke M
Universitätsklinik und Poliklinik für Innere Medizin III, Department für Innere Medizin, Universitätsklinikum Halle, Saale, Deutschland.
Internist (Berl). 2013 Jan;54(1):51-62. doi: 10.1007/s00108-012-3090-x.
Infective endocarditis is a serious disease that is often diagnosed with a considerable delay in clinical practice and therefore has a high mortality rate; therefore, early diagnosis and antibiotic treatment are extremely important. Epidemiological shifts in the age profile, new risk factors and the increasing use of intravascular prosthetic materials have led to changes in the microbial spectrum and clinical symptoms, which must be taken into account in the diagnostic efforts and therapy. Nonspecific symptoms and the increase in nosocomial endocarditis, especially in critically ill and immunocompromised patients require a high level of diagnostic expertise. With diagnostic algorithms based on guideline recommendations antibiotic treatment has to be initiated as early as possible. For patients with severe infective endocarditis a cardiac surgeon has to be involved from an early stage of the disease as in about 50 % of cases conservative antibiotic therapy alone does not alleviate the infection. Also early surgical treatment should be sought with the onset of complications. After effective treatment and patient survival there will always be an increased risk of suffering from renewed endocarditis. This is taken into account in the new recommendations of the European Society of Cardiology for the prevention of infective endocarditis.
感染性心内膜炎是一种严重疾病,在临床实践中常常被诊断延迟,因此死亡率很高;所以,早期诊断和抗生素治疗极为重要。年龄分布的流行病学变化、新的危险因素以及血管内假体材料使用的增加,导致微生物谱和临床症状发生改变,在诊断工作和治疗中必须予以考虑。非特异性症状以及医院内感染性心内膜炎的增加,尤其是在重症和免疫功能低下患者中,需要高水平的诊断专业知识。基于指南建议的诊断算法,抗生素治疗必须尽早开始。对于重症感染性心内膜炎患者,疾病早期就必须有心脏外科医生参与,因为在大约50%的病例中,仅靠保守的抗生素治疗无法缓解感染。并发症出现时也应尽早寻求手术治疗。有效治疗和患者存活后,再次发生心内膜炎的风险总会增加。欧洲心脏病学会预防感染性心内膜炎的新建议中考虑到了这一点。